Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.

Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J.

Arch Dis Child. 2011 Jul;96(7):643-7. doi: 10.1136/adc.2009.176990. Epub 2011 Mar 17.

PMID:
21415043
2.

Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2014 Oct 30;(10):CD010236. doi: 10.1002/14651858.CD010236.pub2. Review.

PMID:
25354543
3.

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

N Engl J Med. 2009 Apr 16;360(16):1597-605. doi: 10.1056/NEJMoa0803531.

4.

Normal intelligence in children with prenatal exposure to carbamazepine.

Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, Nylund T, Bardy A, Kaaja E, Granström ML.

Neurology. 2004 Jan 13;62(1):28-32.

PMID:
14718692
5.

The longer term outcome of children born to mothers with epilepsy.

Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW.

J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1575-83.

6.

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23.

7.

Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.

Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J; Liverpool and Manchester Neurodevelopmental Study Group.

Arch Dis Child Fetal Neonatal Ed. 2006 Mar;91(2):F90-5. Epub 2005 Oct 20.

8.

Child development following in utero exposure: levetiracetam vs sodium valproate.

Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA; Liverpool Manchester Neurodevelopment Group; UK Epilepsy and Pregnancy Register.

Neurology. 2011 Jan 25;76(4):383-9. doi: 10.1212/WNL.0b013e3182088297.

9.

Early cognitive development in children born to women with epilepsy: a prospective report.

Bromley RL, Mawer G, Love J, Kelly J, Purdy L, McEwan L, Briggs M, Clayton-Smith J, Shi X, Baker GA; Liverpool and Manchester Neurodevelopment Group [LMNDG].

Epilepsia. 2010 Oct;51(10):2058-65. doi: 10.1111/j.1528-1167.2010.02668.x. Erratum in: Epilepsia. 2012 Aug;53(8):1470. Sin, Xin [corrected to Shi, Xin].

10.

Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.

Campbell E, Kennedy F, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ, Craig J, Morrow J.

J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1029-34. doi: 10.1136/jnnp-2013-306318. Epub 2014 Jan 20.

PMID:
24444855
11.

A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.

McVearry KM, Gaillard WD, VanMeter J, Meador KJ.

Epilepsy Behav. 2009 Dec;16(4):609-16. doi: 10.1016/j.yebeh.2009.09.024. Epub 2009 Nov 4.

12.

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F; EURAP study group.

Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5.

PMID:
21652013
13.

IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.

Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, Gummery A, Kneen R, Loring DW, Mawer G, Meador KJ, Shallcross R, Clayton-Smith J; Liverpool and Manchester Neurodevelopment Group.

Neurology. 2015 Jan 27;84(4):382-90. doi: 10.1212/WNL.0000000000001182. Epub 2014 Dec 24.

14.

Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.

Veiby G, Daltveit AK, Schjølberg S, Stoltenberg C, Øyen AS, Vollset SE, Engelsen BA, Gilhus NE.

Epilepsia. 2013 Aug;54(8):1462-72. doi: 10.1111/epi.12226. Epub 2013 Jul 19.

15.

The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.

Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, García-Fiñana M, Kneen R, Lucas SB, Shallcross R, Baker GA; Liverpool and Manchester Neurodevelopment Group.

J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637-43. doi: 10.1136/jnnp-2012-304270. Epub 2013 Jan 31.

16.

Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.

Zeng K, Wang X, Xi Z, Yan Y.

Clin Neurol Neurosurg. 2010 May;112(4):291-5. doi: 10.1016/j.clineuro.2009.12.014. Epub 2010 Jan 13.

PMID:
20071075
18.

Effects of breastfeeding in children of women taking antiepileptic drugs.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Neurology. 2010 Nov 30;75(22):1954-60. doi: 10.1212/WNL.0b013e3181ffe4a9. Epub 2010 Nov 24.

19.

Common antiepileptic drugs in pregnancy in women with epilepsy.

Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J.

Cochrane Database Syst Rev. 2004;(3):CD004848. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD004848.

PMID:
15266543
20.
Items per page

Supplemental Content

Write to the Help Desk